Vickram Vijay Anand
Overview
Explore the profile of Vickram Vijay Anand including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
92
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Anand V, Koh J, Teo T, Chin Y, Mahesh R, Chan M, et al.
Clin Res Cardiol
. 2024 Nov;
PMID: 39531081
Purpose: This meta-analysis investigates the sex differences in mortality risk between the acute coronary syndrome (ACS) population without standard modifiable risk factors (SMuRF-less) and those with at least one standard...
2.
Koh J, Mohamed A, Kong G, Wong E, Chen Y, Anand V, et al.
Diabetes Obes Metab
. 2024 Nov;
27(2):683-696.
PMID: 39529446
Objective: Metabolic dysfunction-associated steatotic liver disease (MASLD) and obesity increases risk of cardiovascular disease. This cohort study examines the prognostic value of MASLD, across body weight categories, in a secondary...
3.
Chong B, Jayabaskaran J, Jauhari S, Chan S, Goh R, Kueh M, et al.
Eur J Prev Cardiol
. 2024 Sep;
PMID: 39270739
Aims: The prediction of future trends in cardiovascular disease (CVD) mortality and their risk factors can assist policy-makers in healthcare planning. This study aims to project geospatial trends in CVDs...
4.
Goh R, Chong B, Jayabaskaran J, Jauhari S, Chan S, Kueh M, et al.
Lancet Reg Health West Pac
. 2024 Aug;
49:101138.
PMID: 39100533
Background: Given the rapidly growing burden of cardiovascular disease (CVD) in Asia, this study forecasts the CVD burden and associated risk factors in Asia from 2025 to 2050. Methods: Data...
5.
Tan B, Pan X, Chew H, Goh R, Lin C, Anand V, et al.
Int J Obes (Lond)
. 2023 May;
47(8):677-685.
PMID: 37253796
Background: Recent studies suggest that tirzepatide, a dual glucose-dependent insulinotropic-peptide (GIP) and glucagon-like peptide-1 receptor agonist (GLP-1 RA), has significant weight loss effects. This systematic review and meta-analysis aims to...
6.
Anand V, Goh R, Nah B, Koh S, Lim J, Neo N, et al.
Front Med (Lausanne)
. 2023 May;
10:1193829.
PMID: 37168269
Background: Health literacy and illness perception play crucial roles in tackling the cardiometabolic disease epidemic. We aim to compare the attitudes, knowledge, self-perceived risks and actions taken, between individuals with...
7.
Anand V, Zhe E, Chin Y, Goh R, Lin C, Kueh M, et al.
Int J Cardiol
. 2023 Apr;
383:140-150.
PMID: 37116760
Background: Low socioeconomic status (SES) is an important prognosticator amongst patients with acute coronary syndrome (ACS). This paper analysed the effects of SES on ACS outcomes. Methods: Medline and Embase...
8.
Chong B, Jayabaskaran J, Kong G, Chan Y, Chin Y, Goh R, et al.
EClinicalMedicine
. 2023 Mar;
57:101850.
PMID: 36864983
Background: Malnutrition and obesity are interdependent pathologies along the same spectrum. We examined global trends and projections of disability-adjusted life years (DALYs) and deaths from malnutrition and obesity until 2030....
9.
Anand V, Zhe E, Chin Y, Lim W, Goh R, Lin C, et al.
Endocr Pract
. 2022 Nov;
29(5):398-407.
PMID: 36396016
Objective: The obesity epidemic is a global health concern with Asian countries facing one of the most rapid rises in obesity rates. However, given the underwhelming long-term efficacy of weight...